Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dynamic ctDNA to Predict and Guide Systemic Treatment in Gastric Cancer
NCT07517107Phase 2Recruiting
- Sponsor
- Fudan University
- Start
- Jan 2026
- Primary completion
- Oct 2028
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in gastric cancer (GC), sponsored by Fudan University. Primary endpoint: Objective Response Rate at 24 months. Started Jan 2026; status: recruiting.
02
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT07517107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07517107.